MetaCap

Cencora (COR) vs Cosmos Health (COSM)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Cosmos Health (COSM) has outperformed Cencora (COR) over the past year, gaining 314.5% versus a loss of 7.3%. Over five years, COR leads with a +182.0% price change compared with -17.6% for COSM. Cencora is the larger company by market cap ($64.71 billion vs $14.1 million), about 4576.5 times the size, while Cosmos Health is growing revenue faster (+19.9% vs +9.3%).

On valuation, Cencora trades at a lower forward P/E (15.6x vs 40.1x for Cosmos Health). Cencora pays a dividend yielding 0.71%, while Cosmos Health does not currently pay one. Cencora converts more of its revenue into profit, with a net margin of 0.5% versus -29.3%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

COR-7.27%COSM+314.45%
+401%+152%-97%
Nov 21, 20251 yearNov 20, 2026
COR+181.36%COSM-23.85%
+555%+213%-129%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

COR versus COSM key metrics
MetricCORCOSM
Share price$339.09$2.81
Market cap$64.71B$14.14M
1-day change-0.63%-2.09%
YTD return+0.40%+464.26%
1-year return-7.27%+314.45%
5-year return+182.03%-17.60%
P/E ratio (TTM)18.89—
Forward P/E15.6040.14
EPS (TTM)$17.95$-13.00
Dividend yield0.71%0.00%
Annual dividend$2.40$0.00
Revenue (latest FY)$321.33B$65.27M
Revenue growth (YoY)+9.31%+19.93%
Net income (latest FY)$1.55B$-19.14M
Gross margin3.57%12.10%
Operating margin0.82%-25.59%
Net margin0.48%-29.33%
52-week high$377.54$14.36
52-week low$244.82$2.20
Distance from 52-week high-10.18%-80.43%
Analyst consensusbuystrong_buy
Avg. price target upside+12.78%+60.14%
Average volume1.29M163.51K
Shares outstanding190.83M5.03M
Employees47,000163
SectorHealth CareHealth Care
IndustryOther PharmaceuticalsOther Pharmaceuticals

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Cencora is about 4576.5 times larger than Cosmos Health by market value ($64.71B vs $14.14M).
  • COSM has outperformed COR by 321.7 percentage points over the past year.
  • Cencora is more profitable, keeping 0.5 cents of every revenue dollar as net income versus -29.3 cents for Cosmos Health.
  • Cosmos Health grew revenue faster in its latest fiscal year (+19.93% vs +9.31%).

About Cencora

COR stock →

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally.

Health Care · Other Pharmaceuticals · 47,000 employees

About Cosmos Health

COSM stock →

Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, the United Arab Emirates, Albania, North Macedonia, and Cyprus.

Health Care · Other Pharmaceuticals · 163 employees

COR vs COSM FAQ

Which is bigger, Cencora or Cosmos Health?

Cencora (COR) is larger, with a market capitalization of $64.71B compared with $14.14M for Cosmos Health (COSM).

Which stock has performed better over the past year, COR or COSM?

COSM returned +314.45% over the past 12 months, compared with -7.27% for COR (price return, excluding dividends). Past performance does not predict future results.

Which pays a higher dividend, Cencora or Cosmos Health?

Cencora pays a dividend yielding 0.71%, while Cosmos Health does not currently pay a regular dividend.

Are Cencora and Cosmos Health in the same industry?

Yes. Both are classified in the Other Pharmaceuticals industry within the Health Care sector.

More comparisons